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Abstract 
 
Biomimetic Proteoglycan Interactions with Type I Collagen Investigated via 2D and 3D 
TEM 
Carli Moorehead 
Michele Marcolong, PhD, PE 
 
 
 
 
 Collagen is one of the leading components in extracellular matrix (ECM), 
providing durability, structural integrity, and functionality for many tissues. Regulation 
of collagen fibrillogenesis and degradation is important in the treatment of a number of 
diseases from orthopedic injuries to genetic deficiencies. Recently, novel, biocompatible, 
semi-synthetic biomimetic proteoglycans (BPGs) were developed, which consist of an 
enzymatically resistant synthetic polymer core and natural chondroitin sulfate bristles. It 
was demonstrated that BPGs affect type I collagen fibrillogenesis in vitro, as reflected by 
their impact delaying the kinetic formation of gels similar to native PGs. This indicates 
that the morphology of collagen scaffolds as well as endogenous ECM could also be 
modulated by these proteoglycan mimics.  
 However, the imaging modality used previously, reflectance confocal 
microscopy, did not yield the resolution necessary to spatially localize BPGs within the 
collagen network or investigate the effect of BPGs on the quality of collagen fibrils 
produced in an in vitro fibrillogenesis model which is important for understanding the 
method of interaction. Consequently, a histological technique, electron tomography, was 
adapted and utilized to 3D image the nano-scale structures within this simplified tissue 
model. BPGs were found to aid in lateral growth and enhance fibril banding periodicity 
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resulting in structures more closely resembling those in tissue, in addition to attaching to 
the collagen surface despite the lack of a protein core. 
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Chapter 1: Introduction 
 
 
 The extracellular matrix (ECM) is crucial for gross function and health thus 
various attempts at improving, restoring, or replacing ECM structures are popular in 
current tissue engineering and biomaterial device approaches. However, there is still 
much uncertainty about the function of many ECM molecules and specifically 
proteoglycans (PGs) (described later). While it is known that they are active in collagen 
fibrillogenesis and organization, some debate still exists on why and how these molecules 
interact with collagen to form the highly complex and specific structures of various tissue 
ECM. This makes any attempt at mimicking or replacing these structures with synthetic 
alternatives very difficult since it is unknown which structural nuances are important and 
which can be neglected. By using a set of biomimetic proteoglycans and adapting a 
molecular imaging technique (electron tomography) capable of delineating the subtleties 
between different ECM molecules, the function of individual proteoglycan motifs can be 
investigated. This thesis accounts the development and adaptation of electron 
tomography to synthetic model tissue structures based on type I collagen and synthetic 
proteoglycan mimics. Furthermore, the use of that system to investigate the role of 
glycosaminoglycans (GAGs) (a component of proteoglycans) and proteoglycan charge 
density on collagen fibrillogenesis is further demonstrated.  
 The remainder of this chapter serves to provide a detailed background on the 
components of native tissue, their currently known function, and the history and previous 
successes of the technique in question (electron tomography). First, the general structure 
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of ECM and collagen fibrilliziation will be addressed, followed by an overview of 
proteoglycan types focusing on small leucine-rich proteoglycans which are known for 
being most active in collagen fibrillogenesis. Next, the effect of decorin and biglycan in 
collagen organization, the SLRPs most frequently studied, will be reviewed in more 
detail since the biomimetic structures utilized in this work most closely resemble those 
specific SLRPs. Finally, a review of the history transmission electron microscopy (TEM) 
on tissue structures, electron tomography, and its previous successes will be discussed 
since this thesis demonstrates an extension of these techniques to a new medium. 
1.1. Extracellular Matrix (ECM) – General Overview 
 Tissues are made of two main components: 1) cells, and 2) the extracellular 
matrix (ECM) that surrounds and supports them. Cells produce and maintain the ECM, 
and the ECM in turn provides attachment points for cells, supports them mechanically 
and biochemically, and serves as a pathway for mechanotransduction. The ECM, in turn, 
is composed of two main structural components: 1) insoluble, fibrous molecules that 
support the tensile properties of tissues, and 2) large, soluble molecules that support the 
compressive properties of tissues by maintaining hydration, in addition to having a 
number of other biochemical and mechanochemical properties (1). Additionally, there are 
a small percentage of small soluble molecules that exist mainly to transduce chemical 
signals but don’t support the mechanical properties of ECM. In most tissues, the fibrous 
component is fulfilled by fibrous collagens (types I and II mainly) covered in more detail 
in Section 1.2 (1-3). The compressive component is fulfilled by a number of molecules, 
but in many tissues, it is largely fulfilled by proteoglycan molecules of various structures 
(1, 4). Proteoglycans are heterogenic molecules that have both a protein and sugar 
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component and will be covered in more detail in Section 1.3 (5). The soluble molecule 
role is fulfilled by many molecules mostly taking the form of protein growth factors, 
hormones, paracrines, and autocrines secreted by cells or delivered to the ECM via the 
vascular system (2). Together, these components support all of the requirements to keep 
cells functional in their individual environments, without which, cells become 
dysfunctional and degenerate into a number of pathological conditions such as arthritis, 
macular degeneration, and various types of organ failure (5, 6). 
1.2. Collagen Fiber Structure 
 Collagen has a hierarchical structure that spans a large scale range from the 
angstrom level to the millimeter level (7). It is a protein composed of repeating triplet of 
amino acids in the Gly-X-Y pattern where X and Y are most commonly proline and 
hydroxyproline, respectively, but can be any amino acid (2, 7). This primary structure 
forms an α-helix secondary structure, and 3 such α-chains together form the precursor 
collagen triple helix monomer unit called procollagen (Figure 1.1) (2, 7).  There are 
several types of α-chains and different types of collagens are delineated by the 
composition of their procollagen triple helices (2). Collagens can be homotrimeric, 
having the same α-chains, or heterotrimeric as is the case with Type I collagen which 
contains 2, α1-chains and 1, α2-chain (2). This formation process occurs intracellularly in 
the rough endoplasmic reticulum before procollagen is secreted by the cell (Figure 1.2) 
(2). Following secretion, the N- and C-terminals of procollagen are processed to form the 
final collagen precursor found in the ECM called tropocollagen which then self-assemble 
into collagen fibrils (2).  
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Figure 1.1: Schematic of structural hierarchy of collagen fibrils. (7) 
 
 
Figure 1.2: Schematic illustration of the secretion of procollagen triple helices into the extracellular space. 
(7) 
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 Each fibril is nominally composed of 5, quasi-hexagonally packed tropocollagen 
molecules in a quarter stagger arrangement (Figure 1.1) that give rise to the Type I 
collagen characteristic banding pattern with 67 nm spacing visible under electron 
microscopy known as D-periodicity (Figure 1.3) (2, 7). This process is regulated tightly 
by a number of molecules including other types of collagens such as Types V and XI, but 
also by small leucine-rich proteoglycans such as decorin and biglycan (2). From there, 
these fibrils may merge or pack together into fibers of various thicknesses and lengths 
depending on the tissue type and together impart the main physical and mechanical 
properties necessary for normal tissue function (2, 7).  
 
 
Figure 1.3: D-periodicity of Type I collagen fibrils as seen under electron microscopy (8). 
 
1.3. Proteoglycans
1.3.1. General Overview 
 Proteoglycan molecules have many and varied structures, yet exist in all tissue 
types with some specific types associated with specific tissues and other found more 
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widely across many tissue types. However, they all share the same general structure; that 
of a protein core with usually one or more glycosaminoglycan (GAG) sugar chains 
attached (9, 10). Although a few, less frequently studied varieties contain no GAG chain 
(Figure 1.4) (9, 10). The GAG chains are sulfated polysaccharides that impart a high 
negative charge density to PGs giving them unique properties in addition to the typical 
‘lock-and-key’ biochemical properties of their protein core; properties that are not well 
understood presently despite nearly a century of investigation (5). Additionally, PGs can 
possess 4 different types of GAG chains (Heparan Sulphate (HS), Chondroitin Sulphate 
(CS), Dermatan Sulphate (DS), and Keratan Sulphate (KS), see Figure 1.5) that each vary 
slightly in sugar unit and/or sulphation pattern and in some cases, have mixed populations 
of GAG chains imparting yet more diversity in structure and function (9, 10). It should be 
noted that there are 3 different types of CS (CS-A-C) Iozzo and co-workers have done 
much to investigate and classify the various structures and summarize this work 
extensively in Reference (9) (see Figure 1.6). In general, proteoglycans are classified first 
by location then by molecular motif (9, 10). Only extracellular proteoglycans are of 
interest with respect to collagen fibrillogenesis since that process occurs extracellularly 
(2). Of the extracellular proteoglycans essentially two varieties exist: Lecticans, those 
that bind to hyaluronic acid (HA) (5, 9, 10), and small leucine-rich proteoglycans 
(SLRPs) which possess only a few GAG chains attached to a long protein core and are 
generally active in collagen organization (5, 9-13). 
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Figure 1.4: Schematic representation of varied proteoglycan structures. (1) 
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Figure 1.5: Molecular structure of various GAG chains (14). 
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Figure 1.6: Classification of all proteoglycans currently under study (9). 
 
1.3.2.  Hyalectans 
 Hyalectans are relatively long core proteins with many GAG chains, generally 
CS, attached to it in a bottle brush configuration most similar to (c) in Figure 1.4 (5, 9, 
10). There are 4 PGs in the hyalectan family: versican, aggrecan, neurocan, and brevican 
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(Figure 1.7) of which aggrecan is most studied (5, 9, 10). They share a globular domain 
which allows the PG to bind to HA thus anchoring it into the ECM and forming a 
macromolecule network which imparts specialized mechanical properties to the ECM (9). 
In the case of aggrecan, the high change density is imparted by more than 100 CS chains 
per molecule (5, 9), acts to sequester salt which in turn produces an osmotic gradient 
which functions to keep cartilage hydrated and gives cartilage it’s high compressive 
strength (4, 9, 15). While the function of other hyalectans is less well understood, it is 
theorized that their function in tissue is similar to that of aggrecan; their role, if any, in 
collagen organization is rarely addressed (9).  
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Figure 1.7: Schematic view of the proteoglycans of the hyalectan family (9). 
 
1.3.3. Small Leucine-rich Proteoglycans (SLRPs) 
 Small leucine-rich proteoglycans all share a relatively short core protein with only 
a few GAG chains attached (5, 9-13). They all share a characteristic leucine-rich repeat 
motif in their protein core imparting the classification and the name (12). It consists of 
LXXLxLXXNxL repeat domains where L is generally leucine, but can be isoleucine, 
valine or any other hydrophobic amino acid, and X or x is any other amino acid (12). A 
good review of the biochemical properties of the SLRP family can be found in Reference 
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(12), however, in general, all SLRPs maintain convex and concave faces formed by the 
central leucine rich-repeat (LRR) domain with one or more GAG chains attached 
generally at one end, or sometimes towards the central regions (11, 12) (See Figure 1.8). 
The protein cores are thought to bind collagen (10-12) while the GAG chains are left to 
interact with each other (5) bridging fibrils together (13). 
 The SLRP family is further broken down into 5 classes based on their gene 
structure (5, 9, 10, 12). Of the 5 classes, class I-III SLRPs are considered the canonical 
SLRPs and all possess at least one GAG chain while class IV and V SLRPs are 
considered ‘part-time proteoglycans’ and normally do not have a GAG chain and thus 
will not be discussed here (9, 10, 12). Figure 1.8 schematically shows the structure of all 
known class I-III SLRPs. In general, class I-III SLRPs all bind collagen (mainly Type I 
collagen), but each class binds to a different site on collagen within the D-periodicity 
banding meaning that there is competitive binding only within SLRP classes (12).  
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Figure 1.8: Schematic representation of class I-III SLRP structure. Blue chains indicate GAG chains with 
faded chains indicating potential GAG chains sites and solids chains indicating experimentally confirmed 
sites (11). 
 
 Class I SLRPs include biglycan and decorin which are both found ubiquitously 
throughout the body in almost all tissues that contain fibrillar collagens with biglycan 
being slightly more specialized (13). Table 1.1 summarizes the characteristics of class I-
III SLRPs. Decorin is a relatively short protein core (36 kDa) with only one GAG chain 
attached to one end (10). The GAG chain’s identity can vary from CS to DS depending 
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on the specific location of the molecule, for example CS in bone decorin (16) and DS in 
skin and cornea decorin (17). Biglycan also comprises a relative short protein core (38 
kDa) with generally 2 GAG chains attached very close together to one end of the core 
protein (10). Again, the identity of the GAG chain can vary from CS to DS depending on 
location with DS associated with bone and cartilage biglycan (17) and CS associated with 
tendon biglycan (11). Dysfunction or down-regulation of these molecules leads to 
different phenotypes depending on the location and identity of the SLRP with biglycan 
knockouts generally exhibiting weak tendons and lower bone mass indicative of less 
efficient biominerialization, and decorin knockouts generally exhibiting fragile skin and 
slow angiogenesis (11). Class I SLRPs bind to the ‘d’ and ‘e’ bands of collagen fibrils 
and thus biglycan and decorin compete for binding when they are found in the same 
tissue type at the same time (12). 
 
Table 1.1: Summary of example SLRP structures and characteristics. Adapted from References (10, 11). 
Class Name GAG 
Size of 
Protein 
Core 
Locations 
Class 
I 
Decorin 
1 CS or 
DS (10) 
36 kDa 
(10) 
Anywhere fibrillar collagens are 
located: skin, tendon, cartilage, 
kidney, muscle, bone, etc. (11, 16) 
Biglycan 
2 CS or 
DS (10) 
38 kDa 
(10) 
Skin, tendon, bone, cartilage, kidney, 
muscle. (11) 
Class 
II 
Fibromodulin 
~4-6 KS 
(10, 11) 
42 kDa 
(10) 
Tendon, ligament, cartilage. (11) 
Lumican 
~4 KS (10, 
13) 
38 kDa 
(10) 
Cornea, skin, widespread in low 
concentration. (11, 18) 
Class 
III 
Epiphycan 
~ 3-5 CS 
and DS 
(10, 11) 
36 kDa 
(10) 
Cartilage; expressed during 
embryonic development. (11, 19) 
Osteoglycin 
~1 KS (10, 
11) 
35 kDa 
(10) 
Cornea, skin, and bone. (11, 20) 
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 Class II SLRPs include fibromodulin and lumican both of which are found in 
many tissue types but are only found in significant amounts in a few specific tissues (11-
13). Lumican is most commonly associated with corneal tissue (11, 18) while 
fibromodulin is associated with tendon, ligament, and cartilage (11) (see Table 1.1). All 
known class II SLRPs contain only KS GAG chains but vary in the number attached (10) 
with the number generally ranging from 3-5 (10, 13). Dysfunction or down-regulation of 
these molecules leads to different phenotype depending on the molecule and location 
with lumican deficiency most commonly associated with opaque cornea and resulting 
blindness, and fibromodulin deficiency associated with weak tendons and osteoarthritis 
(11). Class II SLRPs bind to the ‘a’ and ‘c’ bands of collagen fibrils  and also compete 
for binding with each other when found in the same tissues, but not with biglycan or 
decorin (12). 
 Finally, class III SLRPs include epiphycan and osteoglycin which are highly 
localized to just a few tissues (11-13). Epiphycan is found in cartilage (11) and 
osteoglycin is found in cornea, bone, and skin (11, 20) (see Table 1.1). It is unknown the 
phenotypic effect of epiphycan knockouts but the proteoglycan is associated with 
cartilage development and is only known to be expressed during embryonic development 
indicating its purpose in chondrogenesis (19). Dysfunction or down-regulation of 
osteoglycin results in a slight skin fragility without the associated corneal opacity as is 
usually seen in other fragile skin phenotypes produced by decorin and lumican 
deficiencies (11); it’s general function is largely not understood (20). Unlike class I and II 
SLRPs, there is no homology in the identity of the GAG chains attached to class III 
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SLRPs; osteoglycin possess KS GAGs while epiphycan possess both CS and DS GAG 
chains (11, 17). It is unknown where class III SLRPs bind to type I collagen largely due 
to the lack of research investigating their purpose and also likely due to the fact that, at 
least in the case of epiphycan, the tissues they localize to do not possess large quantities 
of banded type I collagen. 
1.3.4. Decorin and Biglycan Function in Collagen Fibrillogenesis 
 Since some of the biomimetic proteoglycans used in this study most closely 
mimic decorin and biglycan structures, further review of their specific effect on collagen 
fibrillogenesis is provided. As stated before, decorin and biglycan are both Class I SLRPs 
and thus bind to the same positions within the type I collagen banding structure although 
there is limited evidence to suggest that this is dependent on either the sample preparation 
or tissue location (11). Since often both SLRPs are found together in many tissues types 
and compete with each other for binding sites (12, 21), it has been proposed that decorin 
and biglycan are redundant with each capable of rescuing the other if one gene becomes 
dysfunctional or damaged (11, 16, 21). This is supported by studies showing similar 
resulting phenotypes in some tissue types when one gene is knocked-out (16, 21), similar 
effects on the kinetics of collagen fibrillogenesis (21), and similar affinity for type I 
collagen (21, 22). However, this effect appears to be tissue dependent since compensation 
is only adequate in corneal and osteoporosis phenotypes (21, 23) and not in myocardial, 
enamel, or skin phenotypes (23-25).  
 It is widely accepted that both biglycan and decorin are active in regulating 
collagen fibrillogenesis (1, 11, 21, 22, 24, 26-28). However, their effects are opposite. 
Decorin is well known to help control the lateral aggregation of collagen fibrils by 
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inhibiting aggregation preventing fibrils from becoming abnormally large (22). 
Conversely, biglycan, while less well studied, seems to aid in fibril aggregation since 
knockout phenotypes show abnormally small diameter fibrils (22). It has been proposed 
that decorin is the main fibrillogenesis regulator with biglycan acting to fine-tune 
aggregation during stages of intense collagen fibrillogenesis such as during tissue 
development (11, 21). Biglycan, possessing 2 GAG chains as opposed to 1 in decorin, 
may be more effective at pulling small fibers together delaying large fiber growth until 
the first stage of fibrillogenesis is complete (11); decorin then taking over to regulate the 
final fibril diameter (11). This is supported by the fact that both decorin and biglycan are 
upregulated during tissue development states (21) and also in tendons where compressive 
stress stimulates increased collagen fibrillogenesis (11), but only decorin remains in 
production once the development phase is complete (11). What is clear is that decorin 
and biglycan have synergistic effects (21, 24) as emphasized when compound knock-outs 
are observed (21). In decorin -/-biglycan -/- mice, corneal structure is completely disrupted 
and non-functional (Figure 1.9) due to fibril disorganization and a large distribution of 
fibril sizes instead of the normal aligned, uniform structure (21).  
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Figure 1.9: Corneal ultrastructure when decorin and biglycan are knocked-out; severe and nonfunctional 
disorganization results. (21) 
 
 A large effort has been made to determine how decorin and biglycan interact with 
collagen to form the highly-ordered structures necessary for proper tissue function. 
Starting with a model proposed by Maurice in 1962 (29), a highly-ordered 6-fold 
arrangement model of SLRPs around a collagen fibril’s diameter and repeating 
periodically along the longitudinal axis of the fiber in the corneal ultrastructure has been 
popular (30). This model has been subsequently modified and enhanced by Scott and 
Knupp in the following years, but it is still theorized that SLRPs attach in a hexagonal 
arrangement around collagen fibrils via their protein cores then bridge fibrils to attach to 
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adjacent fibrils via electrostatic interactions between GAG chains. This results in a gel-
like matrix hydrated by the negative charges on the GAG chains that is proposed to 
regulate the critical spacing between collagen fibrils in the corneal stroma via an osmotic 
pressure balance. While some research suggests that interaction may also occur between 
collagen and the GAG chains themselves, the main interaction is thought to occur 
biochemically via a collagen binding domain on the SLRP core protein. Much debate 
exists on the topic within the field. 
1.4. Biomimetic Proteoglycans 
 Due to the prevalence of proteoglycans in ECM and their role in controlling the 
all-important collagen ultrastructure, in addition to their susceptibility to degradation 
during inflammatory pathologies leading to tissue degeneration, PG mimetic 
replacements have been developed. These mimics possess a synthetic core that lacks the 
recognition sequence for inflammatory enzymes thus protecting them from being 
degraded once introduced into an inflammatory environment and also simplifying their 
production since recombinant proteins are not necessary (31, 32). However, since the 
GAG bristles remain natural CS (the most common GAG bristle type in the body), they 
still conserve the same charge density and glyosidic properties of natural PGs. This 
ultimately allows for the decoupling of protein PG effects from GAG PG effects which is 
currently a contested topic within the field. 
 To date, several types and sizes of BPGs have been developed allowing for the 
study of the effect of PG charge density, size, and bristle spacing on various ECM 
formation and remodeling to be investigated (31, 32). Using two different length of 
poly(acrylic acid) (PAA), PAA/CS aggrecan mimics have been synthesized representing 
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large (~200 nm backbone with ~55-60 CS bristles, referred to as BPG-250 throughout 
this text) and medium sized (~10 nm backbone with 5-10 CS bristles, referred to as BPG-
10 throughout this text) PGs (32). Additionally, using poly(ethylene glycol) (PEG)-
diglycidal ethers (DGEs), SLRP mimics containing a relatively short backbone (2-5 nm) 
and 1-2 CS bristles have been synthesized (refered to as BPG-0.5 throughout this text) 
(31). Previous work using confocal reflectance microscopy (second-harmonic generation) 
has shown that the large and medium BPGs delay collagen fibrillogenesis similar to the 
effect seen with decorin (33). However, the resolution capability provided by confocal 
microscopy is not high enough to delineate more subtle differences in collagen fibril 
morphology nor can it allow for the visualization of the BPGs themselves (33). Thus the 
development of another technique that circumvents these issues was necessary.   
1.5. Transmission Electron Microscopy 
1.5.1. Overview 
 Since the invention of microscopy in the late 1500s (34), resolution has been 
limited by the Abbe law (Eq. 1) which is also known as the diffraction limit (35). It states 
that resolution, d, is proportional to the wavelength of energy used, 𝜆, thus to achieve 
higher resolutions (smaller d), a smaller wavelengths are favorable (35).  
𝑑 =
𝜆
2𝑛 𝑠𝑖𝑛(𝜃)
 𝐸𝑞. 1 
 Since visible light is only in the range 400-700 nm (36), this limits the resolution 
of even the best optical microscopes to approximately 0.5 µm which is far too large to see 
most extracellular structures of interest (36). To overcome this challenge, transmission 
electron microscopes (TEMs) were invented. Electrons have a much shorter wavelength 
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and thus the resolutions achievable are much higher (37).  The current resolution limit is 
around 0.05 nm allowing for the visualization of atoms given the proper conditions with 
the visualization of ECM molecules trivial given proper sample preparation (38). 
 Bright field (BF) transmission electron microscopy (TEM) works essentially the 
same way that bright field optical microscopy works, using sample thickness to attenuate 
the amount of light/electrons transmitted and thus form an image (39). However, since 
most cellular structures are generally made out of similar materials, all variations of 
polymers (proteins), some form of contrast must be introduced to differentiate between 
structures (39). In optical microscopy, creating contrast is simple by changing the color 
of the structure of interest by marking it with a dye molecule and recording light at 
different wavelengths (colors) (36). In electron microscopy, separating out wavelengths 
of electrons is very difficult and thus for all practical applications, electron microscopy 
can only be done in gray-scale. Thus to provide contrast, only two options are left: 1) use 
thickness to attenuate the number of electrons transmitted or 2) introduce electron 
attenuation by selectively adding heavy metal atoms on the structures of interest (39). 
The first approach is difficult to use since a requirement for TEM is that samples be 
electron transparent (39). This limits sample thickness to around 100 nm or less and that 
is not enough of a range to provide any real thickness contrast in BF TEM (39). The 
second approach is much more viable. Since electrons, unlike light, are charged, they 
interact with the protons contained in the nucleus of atoms (39). Atoms with more 
protons, a higher Z number, thus attenuate light more heavily than light atoms (39). This 
gives rise to the practice of using heavy-metal (high Z number) stains to selectively 
provide contrast to biological and polymeric structures (39).  
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 Additionally, since many biological and polymeric materials are non-conductive, 
issues with beam damage and sample vaporization can occur (39). Using a heavy metal 
stain also prevents this issue since the conductive atoms provide a pathway away from 
the delicate polymers to diffuse the high voltage of the beam without damage (39). 
Adding a conductive film below the sample also helps with this issue thus carbon films 
are a common substrate for polymer TEM samples (39). Finally, by reducing the 
accelerating voltage used (often to 80 or 120 kV instead of the usually 200 kV), the 
sample can further be protected from damage (39). 
1.5.2. Collagen Electron Microscopy 
 The use of TEM in histology was developed due to its ability to see and thus 
study ECM structures. In particular, TEM histology has been used to study collagen 
structures since they are so prevalent and varied throughout the body (1, 8, 40-46). The 
resolution EM provides is optimal to study the subtle, yet far-reaching changes that 
different pathological and normal tissue states have on collagen fibril morphology. 
However, since all cellular components are composed of carbon-based molecules, heavy 
metal stains are a requirement for both contrast and beam protection (37, 39), as outlined 
previously. Commonly, stains are used in combination and delivered via solution once 
the sample is mounted on the grid to build up both contrast and protection on the sample.  
Typical stains include the non-selective, negative stain, uranyl acetate (UAc) which is 
used in almost all polymeric and histological TEM (37, 47). Negative stains coat only the 
areas of the grid where no sample exists leaving the sample distinct from the saturated 
background (47). Other common stains include phosphotungstic acid (PTA) (47) and lead 
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citrate (37), which both gather in the striations of collagen fibrils, enhancing the contrast 
of those elements. 
 Typically, the study of collagen fibrils using TEM is performed on tissue samples 
harvested from both animal models (both normal and pathological) and human donors (1, 
8, 40-46). Since whole tissues are used and are of interest to study intact, most EM 
histology procedures call for the fixation, dehydration, embedding, and sectioning of 
samples into thin stable sections using an ultramicrotome prior to mounting on a TEM 
grid and staining with the appropriate metallic stains (37). To date, little literature has 
been published focusing on the imaging of ECM structures using tissue models rather 
than whole tissue.  
1.5.3. Proteoglycan Electron Microscopy 
 The study of proteoglycans using electron microscopy, and particularly the effect 
of SLRPs and SLRP dysfunction, is responsible for the groundwork of much of what we 
understand about such molecules and their interactions with collagen to date. Pioneered 
by J.E. Scott and co-workers in the 1960s-80s, who first successfully visualized GAG-
rich structures between collagen fibrils within corneal tissue, the real advantage to their 
technique was the ability to differentiate well between collagen structures and GAG 
structures using a cationic copper-based dye molecule which selectively associates with 
the negatively charged sulphonyl groups prevalent on GAGs (1, 3, 41, 46, 48-51). While 
several iterations of dye molecules have been used, all are based on organic copper 
phthalocyanine molecules (Figure 1.10) which consist of a copper cation coordinated 
with four tertiary amines (46, 52). Each amine is part of a stable conjugated crown ring 
structure which stabilizes the copper cation and provides a strong, dark blue color to the 
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dye (52).  Molecules within this family of dyes differ only by the groups attached to the 
central crown ring structure to modulate solubility and include Alcian Blue, Cuprolinic 
Blue, and Cupromeronic Blue, the dye used by Scott and co-workers (46). These dyes are 
thought to associated with proteoglycans specifically due to the strongly positively 
charged copper cation which is only partially neutralized by the partial negative charges 
available on the tertiary amine groups (46). The strong negative charge is attracted to the 
negative sulphonyl groups present on all GAG chains thus saturating those structures 
with an additional heavy metal (copper) and providing contrast under EM (46, 51). Much 
work has been done using these dyes in both PG EM and PG optical histology (1, 3, 18, 
41, 43, 44, 46, 48-51).  
 
 
Figure 1.10: Copper phthalocyanine dye backbone (52). 
 
 Additionally, work has been conducted to determine if conditions can be 
modulated to control the specificity of this dye for specific PGs (CS vs. Hyaluronic Acid, 
for example) since not all the sulphonyl bonding environments are the same (50, 51). It 
has been found that adding a competitive cation via the critical electrolyte concentration 
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method in various amounts blocks the binding of the dye molecule preferentially from 
PGs with differently bonded oxygen esters  (HA and HS first) while leaving more 
strongly charged GAGs still stained (51). However, despite the initial successes with 
these dye molecules, they are still very difficult to work with due to low solubility in 
aqueous solutions (despite the addition of more polar edge groups) and the need to use 
relatively low pHs (51). For this reason, the use of another staining approach would be 
highly beneficial. 
1.5.4. Electron Tomography 
 Up to this point, all the previous discussion has been devoted to TEM sample prep 
and 2D BF TEM imaging. However, BF TEM imaging techniques can be capitalized on 
in order to capture 3D BF TEM images known as TEM tomography or electron 
tomography (53, 54). Similar to micro-computer tomography (MicroCT, the materials-
specific version of a CAT/CT scan used in medical imaging), or MRI imaging, 
tomography is an algorithmic technique which uses a series of 2D images taken at 
different angles with respect to the central axis of the material/patient to back-calculate a 
3D representation of the patient/sample itself (53, 54). When applied to TEM images, this 
technique allows for 3D imaging at a molecular scale and as such allows for spatial 
relationships between ECM molecules to be determined (18, 43, 44).  
 TEM tomography, as opposed to other tomographies, presents an additional set of 
challenges. Unlike all other forms of tomography, the relatively 2D nature of TEM grids, 
cannot be loaded using normal samples holder configurations to ensure that the central 
axis of the feature of interest is aligned with the rotation axis. Instead, the central axis of 
the 3D sample follows a eucemtric pathway that must be corrected for during acquisition 
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via image shifts or stage shifts or else the area of interest will move out of the field of 
view after just a small fraction of rotation angles (54, 55). This is achieved through a 
least-squares tracking of fiducial markers, often in the form of 10 nm gold nanoparticles, 
which are used to realign the sample after each rotational image (54). Care must also be 
taken to ensure that no grid bars or grid edges rotate into the beam field thus blocking the 
beam pathway during imaging and preventing images from being recorded. This requires 
that areas of interest be placed towards the center of the grid and that large grid meshes 
be used rather than smaller grid meshes which are more robust to handling (54). All of 
this also limits the resolution achievable since the sample shifts required must be larger 
than the tolerance for motion control of the electronic microscope stage motors which is 
relatively large with respect to most TEM sample features (54). Surprisingly, this isn’t a 
significant issue for most ECM imaging since the molecules of interest are relatively 
large (on the order of 50-200 nm) (18, 43, 44). 
  Another challenge, again related to the 2D nature of TEM grids, is the inability to 
image at a full 360 degree rotation (54, 55). Indeed, most instruments, even if equipped 
with high tilt holders specially designed for tomography, only allow for rotation from -60 
degrees- +60 degrees (54, 55). While reconstruction algorithms can compensate for only 
180 degrees of data, when more than half of the rotations angles are missing, certain 
essential views are missing which are required to completely recapitulate the object of 
interest (54, 55). This leads to incomplete, yet none the less useful datasets, which again 
limit the resolution of the reconstruction and can also introduce distortions that must be 
compensated for during post-processing making the alignment and reconstruction of such 
image series challenging as the resolution increases (54, 55).  
27 
 
 Finally, issues related to the sensitiveness of polymer samples to beam damage 
again resurface since tilt series must be acquired over a relatively long period of time (30-
90 min on average) (54). Samples must be stained and stable enough to withstand a high 
beam saturation for long periods of time without shrinking, vaporizing, or moving with 
respect to the support film all of which will again complicate the reconstruction process 
by adding in unpredictable image shifts and distortions (54). 
 Even with all the challenges associated with tomography, tomograms of ECM 
structures have successfully been captured. Work performed by Knupp and co-workers 
on corneal tissues (Figure 1.11), has elucidated the function of PGs within corneal tissue 
as well as consequences of dysfunction as investigated through murine knock-out models 
(18, 43, 44). The result was beautiful reconstructions able to be segmented, or separated 
into their constitutive structures based on contrast thresholds, for 3D image analysis 
providing more robust statistical morphological information about the ECM structures 
under investigation (18, 43, 44). Used in tandem with other techniques and analysis 
softwares, TEM tomography presents a robust imaging technique for investigating the 
effect of PGs on ECM structure and morphology development. 
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Figure 1.11: Corneal tissue electron tomography models generated by Knupp and co-workers (43). Panel 
shows anterior (a-b), mid (c-d), and posterior (e-f) corneal tissue (43). Scale bar = 50 nm. 
 
1.6. Goal and Project Overview 
 The objective of this study is thus to adapt and develop the technique of TEM 
tomography to highly hydrated tissue models which allow for the decoupling of 
interactive effects between both individual ECM molecule species and distinct molecular 
motifs within individual ECM species. By using a Type I Collagen hydrogel 
fibrillogenesis model used previously to study collagen formation and PG effects (33, 45, 
56-59), and modulating the fibrillogenesis using biomimetic proteoglycans which 
themselves decouple the GAG PG components from their proteinatious core, the effects 
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of each of these individual components can be studied without the confounding effects of 
other biological molecules interfering.  
Using a collagen hydrogel model presents specific challenges for this technique 
since it is first and foremost, a non-solid material that cannot be processed the same way 
as normal solid tissue samples. More closely resembling a nanofiber hydrogel, this model 
does not possess any fibril alignment thus making it difficult to produce thin sections that 
do not transect the large fibrils and PG mimics of interest. For this reason, tissue model 
TEM samples were prepared as hydrogel samples are (45); by forming the hydrogel then 
re-dissolving it in water to dilute it allowing small volumes to be evaporated onto the 
support films of TEM grids. Additionally, due to the challenges associated with using 
copper phathalocyannine dyes, the use of other heavy metal cationic dyes, namely cesium 
chloride (CsCl), that do not possess the bulky, organic fluorophore component that make 
phathaloncyannic dyes so difficult to work with were investigated. After developing this 
technique, the effects of BPGs on Type I collagen fibrillogenesis were preliminarily 
investigated to show the efficacy and usefulness of the technique for the chosen 
application.
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Chapter 2: Technique Development 
 
2.1. TEM of Single Molecule BPGs 
2.1.1. Overview 
 Before attempting to image BPGs already integrated into a collagen matrix, it is 
important to first image single BPG molecules in order to help make identification of 
BPGs within a matrix easier and more accurate. This also provided a useful proof-of-
concept platform to determine the specificity and efficacy of staining methods to be used 
later-on to distinguish BPGs from the surrounding collagen matrix.  This was done by 
depositing molecules in solution onto a TEM support film as has been done to image 
proteins or other nanoparticles (60) to obtain 2D images of single molecules. 
2.1.2. Methods 
2.1.2.1. Baseline Single Molecule TEM Sample Preparation 
 Solutions of all BPG molecules were first prepared at a concentration of 1 mg/mL 
in DI H2O. CS, BPG-0.5, BPG-10, and BPG-250, and commercially purified aggrecan 
were imaged. Next, 10 uL of sample were applied by pipetting to a carbon coated, 200-
square mesh copper TEM grid (20-30 nm Extra Thick, Electron Microscopy Sciences, 
Hatfield, PA) suspended in midair via reverse grip forceps. The molecules were allowed 
to adsorb to the support film surface covered for 60 min then any remaining solution was 
wicked away with a torn edge of filter paper. 
For the grids stained with the standard negative stain, uranyl acetate (UAc) was 
used. 10 uL of 3% UAc in DI H2O was applied to the grid and allowed to adsorb covered 
31 
 
for 20 min then removed using a torn edge of filter paper. The process was repeated a 
second time to ensure adequate staining.  
2.1.2.2. CsCl as a Specific Stain for PGs Sample Prep 
For the samples stained with CsCl, two staining methods were employed. CsCl 
was used since the heavy metal cation is known to associate strongly with the negative 
charges present on PGs already (61). First, pre-staining of BPGs before adsorption to the 
TEM grid was attempted. A 25 mg/mL solution of BPG-250 was prepared in a solution 
of 50 wt% CsCl in DI H2O (corresponding to a density of 1.5 mg/mL, the same density 
typically used in PG isolation procedures). The solution was agitated for 48 hrs to allow 
for the Na+ present on the CS to exchange with Cs+, then dialyzed in 1 kDa pre-wetted, 
regenerated cellulose dialysis tubing against DI H2O for 24 hrs with agitation to remove 
excess salts in solution. Finally, the resulting BPG solution was lyophilized until dry then 
reconstituted in DI H2O at a concentration of 1 mg/mL for deposition onto a TEM grid. 
Deposition was carried out as described previously for single molecule imaging. 
For the deposition-supersaturation method where aqueous CsCl was applied to 
samples pre-adsorbed to a grid similar to the method of application for UAc many EM 
stains, solutions of 12.5 and 2.5 wt% CsCl in DI H2O were prepared and used to stain 
selectively for BPGs. Samples were stained using the same procedure as those stained 
with UAc. 10 uL of CsCl solution was applied to the grid pre-adsorbed with BPG 
molecule, allowed to adsorb for 20 min, the wicked away with a torn edge of filter paper 
in duplicate.  
Additionally, for both procedures, samples stained with both UAc and CsCl were 
prepared as a negative control to check for specificity. CsCl was applied first as described 
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previously, then UAc was applied over top of the CsCl already present, as described 
above. 
2.1.2.3. Gold Nanoparticles as a Specific Stain for PGs Sample Prep 
Finally, it was observed during the assessment of the grids prepared for 
tomography, that when BPGs were present, clustering of gold nanoparticles was 
observed. This was thought to be due to aggregation of the positively charged surface of 
the nanoparticles to the negatively charged GAGs on the BPGs and thus was further 
investigated as a third method to distinguish between PG structures within a collagen 
matrix. 5 uL of 10 nm colloidal gold nanoparticles diluted 20-fold from the stock 
concentration (MP Biomedicals, LLC, Solon, OH) were applied by pipetting to the 
surface of a grid pre-adsorbed with BPG-10 molecules. The grid was allowed to dry 
completely before storing and imaging. A BPG-10 grid stained with 2x UAc was used as 
the positive control. 
All samples were imaged at 80 kV on a JEOL 2100 Lab6 filament gun TEM 
(JEOL USA, Peabody, MA) equipped with a CCD camera (Gatan, Pleasanton, CA). 
2.1.3. Results and Discussion 
2.1.3.1. Single BPG Molecule Baseline Imaging 
Figure 2.1 shows example images of all the macromolecules used in this study. 
As can be seen, UAc provides enough contrast from the background to allow for 
visualization of all molecules when they are visualized on their own, (i.e. when there is 
not strongly absorbing collagen matrix inducing high contrast) without the need for 
additional staining specific for the charged GAG chains. Sizes of all the macromolecules 
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were congruent with the expected sizes based on the known molecular weights. CS was 
identified as approximately 20-30 nm in length correlating to a sugar of approximately 22 
kDa in molecular weight, with BPG-.05, BPG-10, and BPG-250 having lengths of 
approximately 20-30, 50, and 200 nm respectively correlating to the sizes of CS with a 
500 Da PEG tail, star-type polymers with a diameter approximately twice the length of a 
22 kDa CS chain (40-50 nm), and the length of a 250 kDa PAA core chain (200 nm) 
respectively. From this, it was concluded that all BPGs used should be able be visualized 
when placed within a collagen matrix with some of the smaller molecules (bare CS and 
BPG-0.5) possibly being difficult to image due to their small size and relatively low 
charge density with which to sequester stain. 
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Figure 2.1: Example images of single BPGs and control molecules under BF TEM. 
 
2.1.3.2. CsCl as a Specific Stain for PGs 
 CsCl is a commonly used to induce a centrifugal gradient during purification of 
PGs from tissue since CsCl when in its aqueous solution forms a monovalent cation with 
a high atomic weight (61). More Cs+ ions can bind to larger PGs containing more GAG 
chains and thus more negative charges, those PGs are effectively heavier than their 
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smaller, less sulphonated counter parts and thus can be separated by centrifugation (61). 
Since the ability of Cs+ to bind to PGs is widely used, it was hypothesized that the same 
property could be leveraged as an EM stain since the high atomic number that gives 
larger PGs their weight is also more strongly absorbs electrons which is a critic property 
for chemicals used as EM stains. 
 Figure 2.2 shows the images obtained through the use of CsCl as an EM stain in 
two separate approaches as outline in the methods above. Staining the GAG chains prior 
to deposition onto the TEM grid (denoted ‘solution stained’ in Figure 2.2), appeared to be 
ineffective likely due to the strong binding of Na+ already present on the GAG chains that 
was too strongly bound to be removed by exchange during the time periods and 
concentrations used. No proteoglycans were able to be distinguished from the 
background on the stained grid while the negative control staining (denoted those stained 
with CsCl + 2xUAc in Figure 2.2), showed PGs remarkably similar to those visualized in 
the positive control staining. 
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Figure 2.2: Example images of the staining of BPG-250 achieved through the use of CsCl as a specific 
stain for the GAG component of PGs. 
 
 The second method used was a deposition-supersaturation method (denoted 
‘deposition’ in Figure 2.2) mimicking the method which most EM stains are applied to 
samples (i.e. applying small amounts of low concentration aqueous stains to sample 
already adhered to grids, allowing it to adsorb, then wicking excess stain away). Two 
concentrations of aqueous CsCl were used (12.5 and 2.5 wt% respectively). The 12.5 
wt% solution was far too concentrated to provide effective staining and large crystals of 
CsCl formed on the surface of the grid during the adsorption period due to the high 
concentration occluding any PG structures present due to their high electron absorption. 
The negative control also showed PG structures similar to the positive control likely due 
to a washing removal of the highly water soluble CsCl crystals during the first application 
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of UAc and subsequent staining with the second application of UAc. The 2.5 wt% 
solution showed better results. The negative control showed no structures as would be 
expected if successful staining was achieved with CsCl while the CsCl only stained 
sample showed the visualization of PGs albeit at a much lower concentration that is seen 
with the positive control likely due to loss during the application of stain since the 
negatively charged PGs are highly attracted to the cationic solution used during staining. 
Furthermore, the lower concentration of CsCl prevented the formation of nanocrystals 
which would occlude the visualization of PGs. 
 From this imaging it was concluded that low concentrations of CsCl could be 
used as a viable EM stain specifically for PGs. However, due to the ability to visualize 
PGs using a simpler method (UAc only) in this particular system and the realization that 
gold fiducial markers aggregate specifically on PG structures (see following section), it 
was decided to use other methods to stain structures in samples destine for analysis. 
2.1.3.3. Gold Nanoparticles as a Specific Stain for PGs 
 Figure 2.3 shows the normal dispersion of gold fiducials on samples in absence of 
negatively charged structures, such as BPGs, as well as staining of BPGs using gold 
nanoparticles during single molecule TEM. When charged structures were not present, 
nanoparticles were well dispersed and little to no aggregation was seen. However, when 
BPGs were present, aggregates of nanoparticles were observed as shown in Figure 2.3. 
Furthermore, aggregates were on the same size order as the BPG molecules in the 
positive control image. From this and the fact that the number of aggregates drastically 
increases with increasing BPG concentration (data not shown), it was concluded that gold 
nanoparticles could be used to increase the contrast between collagen structures and 
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BPGs. While BPGs are still distinguishable from the background using only UAc 
staining and it is generally more advantageous to have nanoparticles dispersed well when 
using them as fiducial markers for image tracking during tilt series acquisition, adding 
another layer of strong contrast specifically to the BPG structures only allows for better 
image segmentation in the final reconstructed tomogram and thus the tracking challenges 
introduced by aggregation can be compensated for by slightly increasing the 
concentration of gold nanoparticles applied. 
 
 
Figure 2.3: Example images of normal dispersion of gold nanoparticles on samples without charged PG 
structures (Collagen Only fibril matrix), BPG-10 structures stained with normal conditions, and BPG 
structures stained with 10 nm gold nanoparticles. 
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2.2. TEM of embedded thin-sectioned samples 
 Next, it was necessary to develop a sample preparation protocol which allowed 
for visualization of the whole matrix. Because most traditional EM histology is 
performed on tissue embedded in thin plastic sections, this approach was attempted first 
in order to elucidate the effect of BPGs on collagen fibrillogenesis. Using protocols 
adapted to the collagen fibrillogenesis tissue model used in this study and in many 
previous studies (33, 45, 56-59), gels containing collagen fibrils only were fixed using a 
standard fix solution in order to show a proof of concept with the intention of later 
augmenting the fix solution with Alcian Blue, a stain for proteoglycans, as used 
previously by other investigators (1, 3, 18, 41, 43, 44, 46, 48-51). However, after 
observing issues with transecting disorganized fibrils during the sectioning process, this 
approach was abandoned for another which was not only technically easier to execute but 
also allowed for the visualization of whole fibrils.  
2.2.1. Methods 
2.2.1.1. Making Collagen Gels 
 Collagen gels were prepared by neutralizing acid soluble type I collagen 
precursors as used to model fibrillognesis in vitro commonly previously (33, 45, 56-59).  
Briefly, rate tail type I collagen solubilized in 0.02 N acetic acid (Corning, Tewksbury, 
MA) stock solution was neutralized on ice using an appropriate amount of 1 N NaOH 
solution. The volume was then reconstituted to a concentration of 1.5 mg/mL using the 
appropriate volumes of 10x and 1x phosphate buffered saline (PBS) at a pH of 7.4.  
 Once the neutralization solution was prepared, the solutions were allowed to 
equilibrate for 30 min on ice before pipetting 10, 50, and 100 µL aliquots (to determine 
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the effect of size on fixation efficiency) onto each divot of a 1 mL empty pipet tip case 
covered in Parafilm. The aliquots were covered and incubated over a 37°C water bath for 
2 hrs before being lifted from the Parafilm and processed further depending on the 
method of TEM sample preparation. 
2.2.1.2. Preparing Formed Collagen Gels for Thin Sectioning in Plastic Films 
 Following fibrillization at 37C, the gels were transferred directly into cold (4°C) 
fix solution. The fix solution consisted of 2.5 vol% EM grade glutaraldehyde in 0.1 M 
phosphate buffer. Phosphate buffer was prepared according to the protocol in Reference 
(62) at a pH of 7.4, then augmented with 2.5 vol% glutaraldehyde. Samples were rotated 
at room temperature for 24 hrs resulting in stable, translucent individual gels that could 
be handled with a spatula. Next, the gels were dehydrated using an ethanol gradient 
consisting of 50, 60, and 70 vol% ethanol then 80, 90, 100, and 100 vol% denatured 
ethanol to remove all water. Gels were submerged in 5x volume of appropriate ethanol 
solution and rotated 20 min at room temperature before draining and placing quickly into 
the next solution. (In some cases, gels were stored in 90 vol% denatured ethanol at 4°C 
for several days before continuing processing.)  
Next, the gels were cleared to remove any excess ethanol that could interfere with 
the crosslinking of the embedding matrix. Propylene oxide (PO) was used as a clearing 
agent due to its highly organic nature, miscibility with both ethanol and the embedding 
matrix, and high volatility. Gels were submerged in 5x volume of 100% PO for 20 min in 
duplicate.  
Next, mixtures of embedding matrix and PO were prepared to slowly infiltrate the 
gels with embedding matrix. EMBed 812 (Electron Microscopy Sciences, Hatfield, PA) 
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embedding matrix was prepared according to the manufacturer’s protocol. 1:1 and 2:1 
mixtures by volume of embedding matrix to PO were prepared by vortexing until all 
embedding matrix dissolved into the PO. Next, the gels were submerged first in 5x 
volume of 1:1 mixture for 20 min, then 2:1 mixture for 24 hrs, then finally 100% 
embedding matrix 2 hrs. 
Finally, the gels were embedded in a polymeric matrix for later sectioning and 
mounting on TEM grids. Fresh embedding matrix was prepared following the same 
protocol and gels were submerged in 5x volume of embedding matrix for 1 hr then 
loaded into a silicon capsule mold for polymerization. Capsule loading was performed as 
follows. First, the tip of the capsule mold wetted with embedding matrix using a transfer 
pipet. Next, three gels per mold (in the case of the final 50 µL gels) were added to the tip 
of the capsule mold with a spatula taking care to not add too much of the embedding 
matrix that the gels were submerged in prior to loading the mold. Next, a #6 lock washer 
(#6 Zinc-plated Steel, Everbilt, Atlanta, GA) was added on top of the gels, leveled, and 
compacted gently to prevent gels from floating during polymerization. Finally, the molds 
were topped off with fresh embedding matrix and polymerized at 60°C for 24 hrs in a 
drying oven. Following polymerization, the mold was allowed to cool thoroughly before 
demolding embedded gels.  
2.2.1.3. Preparation of TEM Grids 
 Embeded gels were sectioned using an ultramicrotome (Leica EM UC6 Cryo-
ultramicrotome, Leica Biosystems, Buffalo Grove, IL). Standard, ¼ in. thick glass knifes 
were used using nail polish to adhere preformed plastic liquid troughs to the knife edge. 
Distilled water was used as the sectioning liquid. 100 nm thin sections were cut and 
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collected on carbon-coated, 200-mesh copper TEM grids (5-6 nm Standard Thickness, 
Electron Microscopy Sciences, Hatfield, PA).  
The sections were then stained using the bubble method (60) where small 
amounts of stain was first pipetted onto a parafilm sheet and grids balanced on the 
surface of the bubble sample side down for staining. 20 uL of stain was used for all stains 
and excess stain was wicked away from the grid with a torn edge of filter paper after each 
stain or wash. First, grids were stained 2 min with 1 wt% phosphotungstic acid (PTA) 
then washed for 30 sec with 1 vol% acetic acid. Next, the grids were stained twice with 3 
wt% uranyl acetate (UAc) for 12 min each washing in between for 30 sec with 1 vol% 
acetic acid. Following staining, the grids were allowed to air dry before placing in a grid 
box for storage until imaging. 
2.2.2. Results and Discussion 
2.2.2.1. Effect of Gel Size on Fixation 
 Three gel sizes were tested to determine how the volume of the gel affected 
fixation. 10, 50, and 100 µL gels were fixed, dehydrated, infiltrated, and embedded as 
described then sectioned. Both the 10 and 50 µL were able to be sectioned without issue 
but expansion of the thin sections over time was observed with the 100 µL gel sections. 
This was ascribed to swelling of the hydrogel once exposed to the aqueous environment 
of the sectioning trough due to inadequate crosslinking of the hydrogel arising from poor 
infiltration of glutaraldehyde to the interior of the gel.  
 It is well known that specimen size can severely limit the effectiveness of 
fixation. This is why a general guideline for fixation with bulky agents, like 
glutaraldehyde, is that all samples be trimmed to within a volume of 1 mm3 (1 µL). 
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However, due to the significantly lower density of the collagen hydrogel tissue model, 
the maximum fixation volume is likely to be higher but still relatively small. Of the sizes 
tested, it was found that this limit lies somewhere between 50 and 100 µL for 1.5 mg/mL 
collagen hydrogels, significantly higher than the histology recommendation. Since larger 
sample gels are easier to manipulate during the dehydration and embedding process, the 
50 µL gels were used for imaging. 
2.2.2.2. 2D Bright Field TEM Imaging 
 Samples mounted on carbon-coated grids and stained were imaged at 80 kV on a 
JEOL 2100 Lab6 filament gun TEM (JEOL USA, Peabody, MA). Figure 2.4 below 
shows an example image. Samples exhibited relatively low transmission due to plastic 
sections with only a few segments of collagen fibrils shown (brackets in Figure 2.4). 
However, characteristic fibril striations were observed indicating that the structures 
imaged were indeed collagen. The short size of the segments was attributed to the 
disorganization of the tissue model produced during in vitro fibrillogenesis and the 
relative thinness of the sections with respect to the size of the fibrils (100 nm of section 
thickness vs. 30-100 nm diameter fibrils). For this reason, it was concluded to pursue a 
different technique for imaging the collagen and BPGs used in this tissue model since the 
lack of alignment would impede statistically significant areas of tissue model from being 
imaged. 
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Figure 2.4: Representative image of 2D BF TEM imaging of collagen fibrils embedded in thin plastic 
sections and stained with PTA and UAc. Red brackets indicated areas where banding striations can be seen. 
 
2.3. TEM of Solution Deposited Nanofibers 
2.3.1. Overview 
 Since the typical histological approach of embedding the tissue model into a 
plastic matrix and thin-sectioning the samples was found to be in-effective for the highly 
disorganized, relatively low density matrix produced using a type I collagen 
fibrillogenesis model, a method typically used to image synthetic hydrogel networks was 
adapted. Hydrogels are notoriously difficult to image under TEM due to their low density 
once dehydrated and high affinity to collect water which will introduce stability issues 
once placed under the high voltage beam of a TEM. For this reason, the practice of re-
dissolving the hydrogel structures by diluting the gels with water then evaporation 
depositing them onto a TEM support film has become popular. Here, electron transparent 
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monolayers of the structural component of the hydrogel (often nanofibers) are formed on 
the surface of the support film and stained using a common negative stain, allowing each 
fiber to be examined individually. This technique is most commonly used for synthetic 
polymers (63-65) but has also been used to some degree to study the formation of 
collagen fibrils (45). 
2.3.2. Methods 
 Collagen gels were prepared as described previously (Section 2.2.1.1). Following 
fibrillization at 37C, the gels were quenched directly into ice cold DI H2O to stop fibrils 
from continuing to grow. The gels were then resolved by vortexing to create a suspension 
of 10-fold dilute collagen fibrils ready to be deposited onto TEM grids for imaging. 
Within 30 min of preparing the collagen fibril suspensions, 10 uL of suspension 
was applied to a carbon coated, 200-square mesh copper TEM grids (20-30 nm Extra 
Thick, Electron Microscopy Sciences, Hatfield, PA) via pipetting as described previously 
for single molecule TEM. The fibrils were allowed to adhere for 60 min then the excess 
solution that had not evaporated was removed using a torn edge of filter paper. Next, the 
grids were stained with uranyl acetate (UAc) to provide contrast during imaging. 10 uL 
of 3% UAc in DI H2O was applied to the grid and allowed to adhere for 20 min then 
removed using a torn edge of filter paper. The process was repeated a second time to 
ensure adequate staining. Samples were imaged at 80 kV on a JEOL 2100 Lab6 filament 
gun TEM (JEOL USA, Peabody, MA) equipped with a CCD camera (Gatan, Pleasanton, 
CA). 
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2.3.3. Results and Discussion 
 Figure 2.5 shows an example image of the collagen matrix able to be visualized 
using the dissolved hydrogel solution-deposition method of sample preparation. In 
contrast to the structures visualized using the embedding-thin sectioning method, many 
fibrils are visible with strong striation patterns evident on most fibrils indicating good 
staining. From this, it was concluded that the solution-deposition method would allow for 
more complete structure visualization of a disorganized collagen matrix than the thin-
sectioning method. Since this method of sample preparation is significantly simpler, 
quicker, and cheaper due to the need for fewer reagents, it was used for all further 
analysis. 
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Figure 2.5: Example image of collagen matrix prepared by the solution deposition method. Red arrows 
indicate areas where strong striation patterns are visible. 
 
2.4. Summary 
 In conclusion, due to the ability to visualize BPG structures using both UAc and 
gold nanoparticles already necessary for tilt-series acquisition later-on, UAc and 10 nm 
gold nanoparticles were used as EM stains for all following samples and the addition of 
traditional, specific PG stains like Alcian Blue were omitted. Similarly, due to the 
challenges associated with imaging a disorganized collagen matrix using an embedding-
thin sectioning preparation procedure, and the ease of preparing collagen matrix samples 
using a solution-deposition method, all samples for analysis were prepared using a 
solution deposition method. While this results in a disrupted matrix making the 
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quantification of any fibril alignment observed meaningless, due to the simplicity of the 
procedure and the ability image a larger number of structures, a solution-deposition 
method was still preferred for this particular application.  
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Chapter 3: Study 
 
3.1. Overview 
 Returning to the goal of this thesis to spatially locate BPGs within a collagen 
matrix and study the effect of BPGs on collagen morphology in much more detail than 
possible with previously techniques, once staining and gel deposition procedures were 
adequately optimized, those protocols were used to answer the questions at hand. 
Samples were prepared of gels augmented with BPGs and the morphology of collagen 
first studied in 2D. Finally, the samples were imaged in 3D to determine the spatial 
relationship of BPGs with respect to the collagen fibrils.  
3.2. Methods 
3.2.1. Making Collagen Gels 
 Collagen gels were prepared as described previously (Section 2.2.1.1). For 
solutions augmented with BPGs or CS, stock solutions of the appropriate molecule were 
prepared in 1x PBS (pH=7.4) at a concentration of 10 mg/mL for all standard 
concentrations (1 mg/mL and 0.1 mg/mL) or 50 mg/mL for high concentrations (10 
mg/mL). For the PAA core control condition, a solution was prepared in 1x PBS 
(pH=7.4) as before, but the concentration of PAA was adjusted to the molar equivalent of 
PAA in BPG250 or 1000x the molar equivalent of PAA in BPG250 (to show an upper 
limit), in order to prevent the pH of PAA in solution from affecting the neutralization pH 
of the collagen too much, and also to account for the fact that most of BPG mass is 
composed of CS bristle not core polymer. Molar equivalence was calculated assuming 
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approximately 60 CS bristles attached to each core (based on conjugation studies 
conducted previously) and a CS bristle molar mass of 20,000 g/mol. Due to the reactivity 
of the BPG-10 and BPG-0.5 cores, core control samples could not be prepared for those 
molecules. BPG/bristle/core/aggrecan augmented gels, appropriate amounts of 
concentrated solutions were added to the collagen neutralization solutions prior to 
fibrillogenesis to yield the concentrations shown in Table 3.1 below.  
 
Table 3.1: Sample matrix showing the concentrations of molecule augmented gels prepared along with the 
number of individual repeats for each condition used to quantify fibril morphology via 2D imaging. A tilt 
series of 1 of each sample type was also acquired in order to generate 3D representative tomograms of each 
matrix type. 
Molecule 
Concentrations Tested 
0.1 mg/mL 1 mg/mL 10 mg/mL 1000 mg/mL 
BPG-250 3 3 3 - 
BPG-10 - 3 - - 
BPG-0.5 - 3 - - 
CS - 3 - - 
PAA-250 - 3 (Molar Equivalent) - 3 (Molar Equivalent) 
 
3.2.2. Preparation of TEM Grids 
 For all imaging, carbon coated, 200-square mesh copper TEM grids were used 
(20-30 nm Extra Thick, Electron Microscopy Sciences, Hatfield, PA). Within 30 min of 
preparing the collagen fibril suspensions, grids were prepped according to the procedure 
outlined previously (Section 2.3.2). Additionally, 1 of each sample type was marked on 
both sides with fiducial markers for easy tracking and alignment of the tilt series during 
tomogram reconstruction. 5 uL of 10 nm colloidal gold nanoparticles diluted 20-fold 
from the stock concentration (MP Biomedicals, LLC, Solon, OH) were applied first to 
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one side of the grid, allowed to dry completely, then 5 uL were applied to the other and 
also allowed to dry completely before storing for later imaging. 
3.2.3. Imaging 
3.2.3.1. 2D BF TEM Imaging for Collagen Morphology 
 Samples mounted on carbon-coated grids and stained were imaged at 80 kV on a 
JEOL 2100 Lab6 filament gun TEM (JEOL USA, Peabody, MA). For each sample, 20 
images of different areas of matrix at various magnifications (12-30 kX) were taken. 
Fibril diameters and fibril bundle diameters were then measured using ImageJ (NIH, 
Bathesda, MD). Fibril bundles were defined as 2 or more parallel fibrils bound together. 
Approximately, 30 fibrils per samples were measured (total of ~90/condition) and ~30 
fibril bundle diameters measured per condition when seen in images (randomly 
distributed from the 3 repeats in each condition). The diameters for each condition 
(primary and bundle) were compared using 1-way ANOVA to confirm no significant 
differences (p<0.05) between repeats. The data was then aggregated for each condition 
and compared across conditions using 1-way ANOVA to determine if BPG molecule or 
concentration had a significant effect (p<0.05) on primary fibril and bundle diameter. 
 The striation spacing on the fibrils was also quantified. 5 fibrils showing typical 
banding observed for that condition were selected and the fast Fourier transform (FFT) of 
the image calculated. The spacing between consecutive bands was measured (see Figure 
3.1) and the average spacing between the most intense FFT band calculated. 1-way 
ANOVA was used to determine if BPG molecule/concentration significantly affected the 
striation spacing able to be visualized on the collagen fibrils.  
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Figure 3.1: Example FFT of a collagen fibril showing a banding pattern (10 mg/mL BPG-250) and the 
determination of striation period by measuring the FFT spacing of the most prominent band. 
 
3.2.3.2. 3D TEM Tomography of Areas that Contain BPGs 
 Samples marked with gold fiducial markers were imaged under the same 
conditions (80 kV on a JEOL 2100 Lab6 filament gun TEM (JEOL USA, Peabody, 
MA)). Tilt series were captured using SerialEM tomography control software at a 
magnification of 12-20 kX. Images were taken from -60° to 60° at an interval of 1° using 
stage movements only to compensate for sample shifts due to the eucentricity of the 
sample holder during rotation. A target defocus of -1 µm was used. 
 Following acquisition, tilt series were reconstructed into tomograms using IMOD 
TEM tomography reconstruction software (66). The tomograms were then exported as a 
2D image stack and post-processed to smooth the structures and recolor for easier 
segmentation using a custom MATLAB (R2016b, Mathworks, Natick, MA) image 
processing code (see Appendix C). Following post-processing, the image stacks were 
loaded into CTAn (Bruker, Allentown, PA), a micro-computed tomography (microCT) 
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rendering software for easier segmentation and visualization. Segmentation was 
performed on the basis of gray-scale intensity. 
3.3. Results and Discussion 
3.3.1. 2D Image Analysis 
Figure 3.2 shows representative images of the collagen matrix for each of the 
conditions studied. As can be seen, as more CS is added (whether free of incorporated 
into a BPG molecule), increased organization results as indicated by more organized 
bundles and more defined striation banding. This is reflected in both the primary fibril 
and bundle diameters (Figure 3.3) and fibril band spacing (Figure 3.4). Collagen 
fibrillized in the presence of either CS or BPGs containing CS have significantly larger 
primary fibrils (see Appendix 3.2). Furthermore, this effect is approximately dose 
dependent (within standard deviation) with increasing concentration of BPG (CS 
proportion in BPGs) resulting in larger primary fibrils. The effect of CS/BPGs on fibril 
bundle diameter is less defined due to the large distribution of sizes observed. However, 
at large BPG (10 mg/mL BPG-250), fibril bundle diameter significantly increases 
(p<0.05) (see Appendix B) with respect to the collagen only control.  
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Figure 3.2: Representative images of the collagen matrix for each of the conditions. Top row shows the 
controls while the lower rows show images for each of the conditions tested in the design matrix. 
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Figure 3.3: Average primary fibril and bundle diameters for each of the conditions tested. * Indicates 
significantly different (p<0.05) from the collagen only control in primary fibril diameter. 
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Figure 3.4: Average spacing between most prominent striation bands as measured by FFT for each 
experimental condition. Insets show typical fibrils exhibiting the highlighted banding periods. 
 
 Striation band spacing presents a clearer, yet slightly more binary indication of 
the effect of BPGs. Collagen fibrillized in the presence of CS in large quantities (either 
free or incorporated into BPGs) have larger striation periods compared with those of the 
collagen only control or collagen fibrillized in the presence of small amounts of CS or 
small BPGs. This effect occurred in a dose dependent manner with a low concentration of 
BPG-250 having a statistically similar (p>0.05) striation period as the collagen only 
control and increasing striation period as the concentration of BPG-250 increased until it 
converged to ~65 nm, very close to the widely reported 67 nm banding pattern observed 
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in healthy type I collagen fibrils. CS too showed this effect indicating that the banding 
period is likely an effect of the CS GAG chain itself rather than the charge density 
established when CS is incorporated into BPGs.  
 PAA, neither at a molar equivalent concentration or 1000x molar equivalent 
concentration (see Appendix B), had an effect on primary fibril diameter, fibril bundle 
diameter, or striation period with respect to the collagen only control indicating that the 
core was not responsible for the effect seen from BPG molecules despite also being 
negatively charged at physiological pH (67). 
 Using striation period as a measure of fibril health, increasing the CS 
concentration (either free or incorporated into BPGs) resulted in significantly healthier 
collagen fibrils more closely resembling the type I collagen seen in most healthy tissue. 
Furthermore, the concentration sweep performed using BPG-250 shows that this effect 
occurs in a dose dependent manner. While the fact that the intermediate concentration of 
BPG-250 shows increased banding period with respect to an equivalent amount of BPG-
10 and BPG-0.5 despite having proportionately less CS due to its higher core weigh 
(BPG-0.5: ~98% CS, BPG-10: ~95% CS, BPG-250: ~94% CS based on expected 
conjugation percentages), would indicate that molecule size and thus charge density may 
also have a secondary effect on banding period, more testing on different concentrations 
of lower MW BPGs and CS would be necessary to determine definitively.  
 While there are many previous studies investigating the effects of GAGs and/or 
SLRPs on collagen fibrillogenesis in vitro, conflicting results are often seen (68) (see 
Table 3.2). This is likely due to inhomogeneity in the source of acid soluble 
tropocollagens since it has been shown that collagens isolated from different tissues and 
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their degree of post processing (i.e. pepsin cleaved or not) has an effect on the d-
periodicity and their ability to interact with other molecules including GAGs, water, and 
salts (45). Collagen fibrilization is also highly susceptible to pH, ionic strength, and 
neutralization and fibrillization incubation periods resulting in difficulty gaining a clear 
picture of the effect of GAGs and PGs on during the fibrillogenesis process (45, 68).  
 
Table 3.2: Comparison of effect of GAGs and SLRPs on collagen in vitro fibrillogenesis in literature. 
Author 
Collagen 
Source 
Observation 
CS Heparin Decorin 
Diameter 
Growth 
Rate 
Diameter 
Growth 
Rate 
Diameter 
Growth 
Rate 
Reese (26) Rat Tail     - - 
Zhang (21) Rat Tail     - - 
Iwasaki (69)  Unspecified     No Effect  
McPherson 
(70) 
Bovine Dermis   +    
Brightman 
(71) 
Bovine Dermis   + +   
Douglas (72) 
Bovine Skin 
and Trachea 
-      
Stuart (68) Rat Tail - +     
Raspanti (58) Bovine Dermis 
No Effect 
or - 
   +  
Bierbaum 
(73)  
Bovine Dermis + +   - - 
  CS   BPGs 
Yang 
(33)/this 
work 
Rat Tail + 
No 
Effect 
  + - 
 
  
 However, in general, decorin, CS/DS SLRPs possessing approximately 1 GAG 
chain per molecule (most similar to the BPG-0.5 molecules), are thought to inhibit the 
fibrllogenesis process resulting in delayed fibril formation (as measured by turbidemetric 
assays) and smaller, more uniform diameter fibrils in a dose dependent manner (11, 26). 
This was the concluded result by Reese et al and Zhang et al, in in vitro studies using 
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acid soluble type I collagen gels isolated from rat tails and not post-processed by pepsin 
(21, 26), the same material used in this study. However, a similar study using acid soluble 
type I collagen from an unspecified source by Iwasaki et al showed no effect of decorin 
on fibril diameter at the low concentrations tested (69). Similar inhibitory effects have 
been observed in decorin knockout and mutated gene models in vivo (16, 21). In general, 
this effect remains when a decorin protein core stripped of its GAG chain (21, 26). 
 Similar confusion exists when the effect of GAGs are investigated (Table 3.2). In 
vitro fibrillogenesis studies by McPherson et al and Brightman et al, irrespective of the 
source of collagen, saw increased fiber diameter when heparin was introduced during 
fibrilization (70, 71). However, Douglass et al, Stuart and Panitch, and Raspanti et al, 
irrespective of collagen source, in an in vitro fibrillogenesis model saw decreased fibril 
diameter or no significant difference in diameter when all types of CS (CS-A-C), CS-C, 
or CS-A-C or GAG chains isolated from decorin, respectively, were added (58, 68, 72). 
Decreases in diameter were also seen due to addition of GAG chains in vivo in a study by 
Ruhland et al (74). Still others have reported no statistically significant effect of CS-A or 
DS on fibril diameter (57). Since the effect of GAG chains alone are less of interest in 
most tissue pathologies, there is less consensus about which effect more accurately 
describes what should be expected under the fibrillization conditions used in this study. 
However, it has been proposed that the effect produced by the GAG is specific to the type 
and molecular length of the GAG in question (45, 58, 72). A previous study by our lab 
saw no statistically significant change in fibrillization lag time or growth rate with the 
addition of CS-A, however lower concentrations of CS were used (33). This work shows 
increased fibril diameter with the addition of CS-A congruent with some of the previous 
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literature on heparin addition but not with the literature reporting the effect of CS-A (58, 
68, 72). This effect was also observed when CS-containing BPG molecules were added 
but not when the core control (PAA) alone was added indicating that the effect is likely 
due solely to the addition of CS rather than charge density introduced by the BPGs.  
 This conclusion is also supported by the changes seen in fiber periodicity. D-
periodicity is known to vary slightly depending on the source and sample preparation 
(45). While d-periodicity is normally 67.0 nm in most wet tissues, that number drops to 
64.0 nm for air dried samples, and 65.0 nm for wet skin tissues (45). Shorter d-periodicity 
can occur as a transient structure during fibrillogenesis and in fibrils polymerized for 
shorter amounts of time (45). For instance, Liu et al fibrillized pepsin-solubilized 
collagen for 12 hrs at 37°C and saw d-periodicities of approximately 44 nm for the 
collagen control (75). However, the most stable structure is a d-spacing of 67 nm due to 
the size of the tropocollagens (45). In this study, d-spacings of approximately 12 nm were 
seen for the non-GAG controls and gels augmented with only low concentrations of 
BPGs. When CS was added (either free or incorporated into BPGs at higher 
concentrations), the d-spacing increases until eventually converging to approximately 65 
nm, within error of the 64 nm dried sample spacing seen in healthy tissue (45). 
Additionally, increasing the charge density (adding CS in the form of BPGs which highly 
concentrates charge) shows decreased periodicity spacing with respect to the equivalent 
concentration of free CS. However, given that some of the CS mass is replaced by 
polymer core, it is difficult to establish the effect of charge density on band spacing 
without further experimentation.  
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 Collagen fibrillization is thought to occur via simultaneous end growth and later 
fibril fusion (21, 45). It is also known to be particularly sensitive to ionic strength since 
growth is thought to be mediated by adsorption of ions onto the surfaces of growing 
fibrils (45). Consequently, it has been proposed that GAGs have the potential to interact 
with collagen electrostatically since most GAGs are essentially polyanions (45, 68, 70, 
72, 76). Within this framework, it has been proposed that GAGs serve as fibril nucleation 
sites bridging adjacent collagen molecules and allowing them to more rapidly organize 
into fibrils (45, 68, 70, 72). However, the consequence of that mechanism has been 
interpreted differently depending on the observed trend. Generally, it is described as 
resulting in a faster growth rate (68, 71). This hypothesis is congruent with what was 
observed in the d-periodicity trends in this study since a faster growth rate would allow 
the fibrils to exit the transient, short d-periodicity stages faster than their un-augmented 
controls. Additionally, if CS is serving as a nucleation site, concentrating it spatially in 
the form of a large BPG (BPG-250), would result in slower growth rates leading to 
stunted d-periodicity and larger fibrils at equivalent or increased concentrations of BPGs 
since CS is no longer free to form a higher number of distinct nucleation sites. However, 
the reverse was observed even though when BPGs were added during fibrillogenesis, 
they were seen to significantly retard growth rate (33). Consequently, it is more likely 
that the mode of action by which CS affects intrafibrillar organization is to enhance the 
stability of the equilibrium state of collagen fibrils (d-spacing of 67 nm) in such a way 
such that the equilibrium structure forms preferentially to the transient structures with 
shorter d-spacings. Since BPGs have also been shown to decrease the fibrilization growth 
rate (33), that effect is likely a result of the charge density produced from concentrating 
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CS into a BPG solely. Thus the property of PGs, in general, to retard fibrilization growth 
rates in vivo, likely serves some other purpose than to affect collagen morphology; such 
as to slow down matrix self-assembly enough to allow for other matrix or cell signaling 
molecules to diffuse through the matrix before assembly into a dense matrix is complete. 
3.3.2. 3D Tomogram Analysis 
 Figure 3.5 shows example segmented tomograms rendered in 3D for both the 
collagen and CS controls and BPG-10 and BPG-250. (BPG-0.5 and PAA tomograms are 
not shown because BPG-0.5 was too small to be visualized within a carbon matrix and no 
effect was seen with the addition of PAA.) Magenta was assigned to the collagen matrix 
background while more electron dense structures, BPGs, were assigned a green color in 
Figure 3.5. CS was too small to be visualized when placed within a carbon rich matrix of 
collagen since it did not have enough charge density to aggregate enough stain to 
delineate it from the collagen matrix background. Consequently, no GAGs appear in 
green in the CS control tomogram. However, it is likely that CS also bound to the surface 
of collagen fibrils due to electrostatic interactions. This was also the case for BPG-0.5 
(not shown). However, BPG-10 and BPG-250 were able to be visualized since the 
aggregated gold nanoparticles due to their high negative charge density. All BPG-10 and 
BPG-250 modified matrices exhibited BPGs attached to the collagen fibril surface either 
wrapping around the fibril or embedded between fibrils (bottom two panels in Figure 
3.5).   
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Figure 3.5: Example segmented tomograms for each of the BPGs able to me identified within a collagen 
matrix along with control tomograms. In each quadrant, (a) denotes full tomogram segmented by grayscale, 
(b) denotes full tomogram segmented by maximum intensity projection (MIP), and (c) denotes the axial 
cross section of the grayscale segmented tomogram at the level of the BPG attachment for those containing 
large BPGs. 
 
 Traditionally, it was though that only the protein cores of SLRPs could interact 
with collagen since they possess specific biochemical lock-and-key binding sites for 
collagen (1, 12, 18, 30, 43, 44, 49, 77-79) although confusion has always existed. Much 
of this confusion stems from a model proposed by J.E. Scott (Figure 3.6) which shows 
the protein cores of SLRPs tethering them to the collagen fibril surface then dimers of 
GAGs interacting with each other (78), regulating the spacing between collagen fibrils 
although Scott himself realized that GAGs also have electrostatic interactions which are 
important for their binding properties (1). Indeed, OBrink showed in the 1970s that 
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GAGs bind type I collagen precursors (76), and Douglas et al echoed this property 
showing that CS-A-C bind both type I and II collagen fibrils  
 
 
Figure 3.6: Model proposed by Scott showing SLRP core proteins attaching to the surface of collagen 
fibrils with GAG chains duplexing with each other to regulate the spacing between fibrils. P indicates the 
area of the protein core. (73) 
 
 More recently, the role of GAGs in the regulatory properties of SLRPs has been 
acknowledged since removal of the GAG chains from decorin causes the GAG-less 
mutant form of decorin to bind less strongly to Type I collagen monomers (74). This 
agrees with what observed in this study where structures lacking a protein core were still 
found to tightly adhere to collagen fibrils (Figure 3.5). Additionally, since these samples 
were processed by re-dissolving and disrupting the collagen matrix vigorously after it 
was formed, the fact that BPGs remained attached to collagen fibrils even after sample 
preparation indicates that the association must be relatively strong. Otherwise the highly 
hydrophilic nature of the BPGs would have likely resulted in their loss to the aqueous 
stains applied after matrix adsorption to the support film. While likely both mechanisms 
(core protein binding and GAG binding) are at work during the regulation of collagen 
fibrillogenesis in vivo, this work indicates that the ability of GAGs to bind collagen must 
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be considered when investigating the mechanism by which SLRPs regulate collagen 
morphology. Which mechanism is more dominant, weather the two mechanisms are 
equally dominant, or whether they work to produce opposite effects on collagen 
morphology are questions that still remain to be answered. This work also serves as a 
proof of concept that BPGs are a useful research tool to completely decouple the effects 
of GAG, core protein, and charge density on collagen fibrillogenesis which has been 
challenging previously. 
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Chapter 4: Conclusions, Perspectives, and Future Work 
4.1. Technique Design 
 While the method developed to image collagen gels is much easier and quicker 
than traditional embedding and sectioning methods, it presents a set of limitations. First, 
that the collagen fibrils (with the exception of those bound into bundles) are not in the 
same organization with respect to each other as they were when first formed. This makes 
it impossible to analyze the effect of BPGs on collagen fibril spacing which is a 
parameter of interest in these systems since PGs are though to regulate collagen spacing 
in tissues like cornea (18, 43, 44, 78). An approach to elucidating that mechanism is to 
grossly align the fibrils via another method during fibrillization so that the organization is 
confined to one plane when the samples are embedded and sectioned and consequently 
fewer fibrils are transected during the sectioning process. Thus the effect of BPGs on 
fibril spacing can be elucidated because the matrix is not being disrupted during the 
sample preparation method. Many methods have been investigated to align collagen 
fibrils during fibrillization including mechanical anisotropy (80, 81), microfluidic 
processing  (82, 83), and magnetic fields (84). One of these methods could be adapted to 
produce aligned matrices during fibrillization so that the effect of PGs on fibril spacing 
can be studied.  
 A second limitation is that small structures (bare CS and BPG-0.5), lacking 
enough charge density to sequester the EM stain, are not able to be visualized using the 
current staining protocol. This can be overcome by using more sophisticated staining 
methods such as immunogold labeling in which secondary antibody ligands attached to a 
gold nanoparticle attach specifically to the molecules via a primary antibody thus 
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attaching an electron dense nanoparticle preferentially to those structures (85). This 
technique has been used previously to visualization proteoglycan location within a tissue 
by Ruhland et al (74) and is fairly common within the field of EM histology (85).  
 A third limitation is in the ability to stain structures specifically when more 
molecular species are added. Since this technique is very useful as a way to evaluate the 
interactions between ECM molecules in a simplified manner or in the context of a tissue 
system, eventually the challenge of being able to distinguish between more than just two 
molecular types will be encountered. This challenge can be overcome by using an 
immunogold technique as described previously. Secondary antibodies attached to 
different sized metallic nanoparticles can be purchased thus different molecular structures 
can be differentiated with different sizes of gold nanoparticles (85).   
 Further development would be necessary to expand this technique’s applicability 
towards more complex applications which are also more relevant to tissue in vivo, but 
this work shows its value as a research tool to begin probing these complex questions. It 
also shows the efficacy of using BPGs as a research tool to begin delineating the 
bioactive functions of non-protein-based ECM molecules, an area of research that is 
traditionally neglected when compared to much larger fields such as genomics or 
proteomics.  
4.2. Effect of BPGs on Collagen Organization 
 While all the concentrations used in this study are well above physiological 
concentrations, necessarily so to ensure that the concentration was high enough to locate 
at least one proteoglycan within the sample specimen, since almost all previous work 
investigating these molecules saw dose dependent effects (33, 70-72), it is assumed that 
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the trends observed at high concentrations also occur at low concentrations. While this 
may be accurate, further experimentation would be necessary to confirm that definitively.  
 Furthermore, while the fibrillogenesis model used is indicative of what occurs in 
vivo when cells secrete tropocollagens, it is highly simplified. The effects seen in this 
study may or may not hold when BPGs are present in remodeling tissue in vivo. An 
extension of this study would be to inject BPGs into a healing wound model where ECM 
molecules are actively being produced and examine their effect on collagen morphology. 
Since the BPGs are actively being assessed as a therapeutic for both early stage arthritis 
and urinary stress incontinence, a better understanding of what effect BPGs have long 
term on the tissue they are injected into is critical for both moving closer to a clinical 
application and also for engineering a second generation of molecules which are more 
effective at regenerating damaged tissue. 
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Appendix A: Terms and Abbreviations Used 
 
 
Term/Abbreviation Definition 
3Dmod Tilt series and reconstruction viewer 
BF Bright Field – mode of microscopy 
BPG Biomimetic Proteoglycan 
CS Chondroitin Sulphate 
CsCl, Cs 
Cesium chloride, Cesium – used for heavy metal staining to 
provide contrast during imaging 
CTAn CT Analysis Software – used for analyzing tomograms in 3D 
CTVox CT Voxel – 3D tomogram rendering software 
DGE Diglycydal Ether 
DS Dermatan Sulphate 
EM Electron Microscopy 
Etomo Reconstruction Software 
FFT Fast Fourier Transform 
GAG 
Glucosaminoglycan – sugar molecules characteristic of all 
proteoglycans 
HS Heparan Sulphate 
IMOD Base Image Processing Software 
KS Keratan Sulphate 
MicroCT Microcomputed Tomography 
Model 
Reconstruction segmented by gray-scale density and recolored to 
isolate features of interest 
PAA Poly(acrylic acid) 
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PEG Poly(ethylene glycol) 
PG Proteoglycan 
PTA 
Phosphotungstic Acid – another heavy metal stain to provide 
contrast during imaging 
Reconstruction 3D volume generated by back-projecting the tilt series images 
Segmentation 
Separating out features of interest by gray-scale density for 
analysis and viewing 
SLRP 
Small leucine-rich proteoglycan – proteoglycans most often 
implicated in collagen regulation 
TEM Transmission Electron Microscope 
Tilt Series 
Set of TEM images taken at different angular positions with 
respect to the image axis – first step of tomography 
UAc 
Uranyl Acetate – another heavy metal stain to provide contrast 
during imaging 
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Appendix B: Supporting Information for Chapter 3 
 
 
Table 4.1: P-values generated using a Tukey multi-comparison post-hoc test following 1-way ANOVA 
comparing the primary fibril diameter of each experimental group. Green boxes containing green text 
indicates p<0.05, blue boxes containing green text indicates p<0.01, and blue boxes containing red text 
indicates p<0.001. 
 
1 
mg/mL 
CS 
1x 
MolEqiv 
PAA 
1000x 
MolEqiv 
PAA 
1 mg/mL 
BPG-0.5 
1 mg/mL 
BPG-10 
0.1 
mg/mL 
BPG-250 
1 mg/mL 
BPG-250 
10 mg/mL 
BPG-250 
0.1 mg/mL 
Aggrecan 
Collagen 
Only 
1.27E-
07 
9.23E-01 9.69E-01 1.64E-06 1.97E-05 0.001 1.23E-03 1.27E-07 9.99E-01 
1 
mg/mL 
CS  
1.31E-07 1.27E-07 3.57E-01 1.30E-01 7.43E-03 0.009 1.00E+00 1.27E-07 
1x 
MolEqiv 
PAA   
2.01E-01 1.67E-03 1.04E-02 1.64E-01 1.50E-01 2.62E-07 4.82E-01 
1000x 
MolEqiv 
PAA    
1.28E-07 1.42E-07 3.80E-06 3.12E-06 1.27E-07 1.00E+00 
1 
mg/mL 
BPG-0.5     
1.00E+00 0.934 9.44E-01 7.22E-01 1.42E-07 
1 
mg/mL 
BPG-10      
9.96E-01 9.97E-01 3.96E-01 4.19E-07 
0.1 
mg/mL 
BPG-
250       
1 4.49E-02 4.46E-05 
1 
mg/mL 
BPG-
250        
5.03E-02 3.70E-05 
10 
mg/mL 
BPG-
250         
1.27E-07 
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Table 4.2: P-values generated using a Tukey multi-comparison post-hoc test following 1-way ANOVA 
comparing the fibril bundle diameter of each experimental group. Green boxes containing green text 
indicates p<0.05, blue boxes containing green text indicates p<0.01, and blue boxes containing red text 
indicates p<0.001. 
 
1 mg/mL 
CS 
1x 
MolEqiv 
PAA 
1000x 
MolEqiv 
PAA 
1 mg/mL 
BPG-0.5 
1 mg/mL 
BPG-10 
0.1 
mg/mL 
BPG-250 
1 mg/mL 
BPG-250 
10 
mg/mL 
BPG-250 
0.1 mg/mL 
Aggrecan 
Collagen 
Only 
0.976 0.999 0.921 0.999 1.27E-07 1.27E-07 0.990 1.49E-07 1.000 
1 
mg/mL 
CS  
1.000 0.219 1.000 1.27E-07 2.81E-07 0.447 2.08E-05 0.715 
1x 
MolEqiv 
PAA   
0.458 1 1.27E-07 1.39E-07 0.725 2.53E-06 0.917 
1000x 
MolEqiv 
PAA    
0.442 1.27E-07 1.27E-07 1.000 1.27E-07 0.999 
1 
mg/mL 
BPG-0.5     
1.27E-07 1.41E-07 0.711 2.85E-06 0.909 
1 
mg/mL 
BPG-10      
0.190 1.27E-07 0.015 1.27E-07 
0.1 
mg/mL 
BPG-
250       
1.27E-07 0.997 1.27E-07 
1 
mg/mL 
BPG-
250        
1.27E-07 1.000 
10 
mg/mL 
BPG-
250         
1.27E-07 
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Table 4.3: P-values generated using a Tukey multi-comparison post-hoc test following 1-way ANOVA 
comparing the fibril main band spacing of each experimental group. Green boxes containing green text 
indicates p<0.05, blue boxes containing green text indicates p<0.01, and blue boxes containing red text 
indicates p<0.001. 
 
1x 
MolEqiv 
PAA 
1000x 
MolEqiv 
PAA 
1 
mg/mL 
CS 
1 
mg/mL 
BPG-0.5 
1 
mg/mL 
BPG-10 
0.1 
mg/mL 
BPG-250 
1 mg/mL 
BPG-250 
10 mg/mL 
BPG-250 
0.1 m/mL 
Aggrecan 
Collagen 
Only 
1.000 1.000 1.27E-07 1.000 0.708 0.035 1.27E-07 1.27E-07 1.000 
1x 
MolEqiv 
PAA  
1.000 1.27E-07 1.000 0.901 0.089 1.27E-07 1.27E-07 1.000 
1000x 
MolEqiv 
PAA   
1.27E-07 1.000 0.939 0.116 1.27E-07 1.27E-07 1.000 
1 mg/mL 
CS 
   
1.27E-07 
1.27E-
07 
1.27E-07 0.071 1.27E-07 1.27E-07 
1 mg/mL 
BPG-0.5 
    
0.956 0.136 1.27E-07 1.27E-07 1.000 
1 mg/mL 
BPG-10 
     
0.815 1.27E-07 1.27E-07 0.965 
0.1 
mg/mL 
BPG-250       
1.27E-07 1.27E-07 1.48E-01 
1 mg/mL 
BPG-250 
       
1.27E-07 1.27E-07 
10 mg/mL 
BPG-250 
        
1.27E-07 
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Figure 4.1: Average primary fibril and bundle diameters for each of the conditions tested including 
aggrecan and 1000x PAA.  
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Figure 4.2: Average spacing between most prominent striation bands as measured by FFT for each 
experimental condition including aggrecan and 1000x PAA. 
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Appendix C: MATLAB Code Used to Post-process Tomogram Image Stacks 
 
 
% Load First Image into MATLAB 
[filename,path,~]=uigetfile('.tif'); 
I = imread([path filename]); 
 
C=strsplit(filename,'.'); % get filename to save modified file 
mkdir(C1); % make new folder for modified images 
cd(C1); % go to that directory so that images are saved to the correct file 
NewName=sprintf('%s_Averaged Voxels_%s.bmp',C1,C2); % generate new filename string 
NewNewImage=TransformImage(I); % transform image accoring to the function commands 
imwrite(NewNewImage,NewName); % write new image as a .jepg 
 
% Open next image in sequence automatically, modify, the save until all 
% images have been modified 
while 1 % continue until no file error is thown then break loop 
    try 
        NextFileNum=str2num(C2)+1; 
        if NextFileNum<10 
            NextFileNum=['0','0',num2str(NextFileNum)]; 
        elseif NextFileNum>9&&NextFileNum<100 
            NextFileNum=['0',num2str(NextFileNum)]; 
        else 
            NextFileNum=num2str(NextFileNum); 
        end 
        I = imread([path sprintf('%s.%s.%s',C1,NextFileNum,C3)]); 
        NewNewImage=TransformImage(I); 
        NewName=sprintf('%s_Averaged Voxels_%s.bmp',C1,num2str(NextFileNum)); 
        imwrite(NewNewImage,NewName); 
        C2=NextFileNum; 
    catch 
        break 
    end 
end 
 
function NewNewImage=TransformImage(I); 
% Fibers 
BW = imbinarize(I,.7); % isolate fibers 
se = strel('disk',1); % create errosion/dilation object 
dilated=imdilate(BW,se); % dilate and errode to connect fiber outlines 
eroded=imerode(dilated,se); 
BW2=bwareaopen(eroded,3); % remove small pixels so that nosie areas within fibers aren't 
left out of smoothing opperation 
 
% Smoothing 
84 
 
NewImage=I; 
smoothed=medfilt2((I), [15 15]); % smoother fiber parts of image with pizels next to it 
so that stirations aren't as promanent 
NewImage(~BW2)=smoothed(~BW2); % replace the fiber parts of the image with the smoothed 
image 
 
% % Gold Nanoparticles 
BW = imbinarize(I,.20); % find areas of images containing gold nanoparticles 
se = strel('disk',7); % create object shape for dilation sequence 
dilated=imdilate(~BW,se); % dilate image to connect gold nanoparticle objects 
se = strel('disk',3); % create object shape for errosion sequence. errosion was not 
performed at same radius to overcome artifical contrast from beam hardening 
eroded=imerode(dilated,se); % errode image to retun gold nanoparticles to normal size 
NewNewImage=NewImage; 
NewNewImage(eroded)=0; % assign gold nanoparticle parts of the image as black pizels for 
easier segmentation 
 
 
  
 
